Transactions

MTS Advised Redx Pharma on a Complex $125mm Financing to Advance its Fibrosis-Focused Programs and its Transition into Nasdaq-Listed Fibrx Therapeutics

MTS served as exclusive financial advisor to CHG Healthcare, a portfolio company of Ares, LGP and GIC, on its acquisition of KREWE Anesthesia

MTS served as exclusive financial advisor to CleanSlate on its sale to Spero Health

Zymeworks Inc. enters into a definitive agreement to acquire Theravance Biopharma, Inc. for $929mm

MTS served as exclusive financial advisor to Knox Lane on its acquisition of Cross Country Healthcare (Nasdaq:CCRN)

MTS served as lead financial advisor to Golden State Medical Supply, a portfolio company of Court Square, on its sale to Revelar Capital

MTS served as financial advisor to Galapagos’ Independent Board of Directors on its collaboration agreement with Gilead Sciences for Ouro Medicines’ assets

MTS served as exclusive financial advisor to CirrusMD on its sale to Quantum Health

MTS served as exclusive financial advisor to Alma on its sale to Spring Health